Concepedia

Patch Contraceptive Safety

Patch Contraceptive Safety is a biomedical risk assessment framework that evaluates the safety profile of transdermal hormonal contraceptive patches through systematic analysis of adverse event incidence, hormonal delivery efficacy, and long-term health outcomes in diverse user populations.

28

Publications

1.7K

Citations

91

Authors

49

Institutions

Publications per year

2017–2026

1

Parents

Publications

28

Evaluation of Contraceptive Efficacy and Cycle Control of a Transdermal Contraceptive Patch vs an Oral Contraceptive<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>

Marie‐Claude Audet · JAMA · 2001 · 336 citations

, , +17

Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 μg of ethinyl estradiol

Susan S. Jick, James A. Kaye, Stefan Russmann et al. · Contraception · 2006 · 179 citations

, , +17

Efficacy and safety of a transdermal contraceptive system1 , *1

Gregory J. Smallwood · Obstetrics and Gynecology · 2001 · 120 citations

, , +17

Assessment of compliance with a weekly contraceptive patch (Ortho Evra™/Evra™) among North American women

David F. Archer, Alison Bigrigg, Geoffrey H Smallwood et al. · Fertility and Sterility · 2002 · 112 citations

, , +12

Further results on the risk of nonfatal venous thromboembolism in users of the contraceptive transdermal patch compared to users of oral contraceptives containing norgestimate and 35 μg of ethinyl estradiol

Susan S. Jick, James A. Kaye, Lin Li et al. · Contraception · 2007 · 107 citations

, , +17

1–5 of 28

Authors

91

  1. GW
    George W. Creasy

    Johnson & Johnson (United States), United States

    5 publications · 346 citations

    5

    h-index

  2. DF
    David F. Archer

    Eastern Virginia Medical School, United States

    5 publications · 195 citations

    5

    h-index

  3. LS
    Larry S. Abrams

    Johnson & Johnson (United States), United States

    4 publications · 241 citations

    4

    h-index

  4. ML
    Marie L. Foegh

    Georgetown University, United States

    4 publications · 83 citations

    4

    h-index

  5. FA
    Frankie A. Wong

    Johnson & Johnson (United States), United States

    4 publications · 241 citations

    4

    h-index

1–5 of 91

Institutions

49

  1. Johnson & Johnson (United States)

    New Brunswick, United States

    9 h-index

    17 publications

    1.6K citations

  2. Eastern Virginia Medical School

    Norfolk, United States

    4 h-index

    4 publications

    170 citations

  3. University of Southern California

    Los Angeles, United States

    3 h-index

    3 publications

    58 citations

  4. Agile Therapeutics (United States)

    Princeton, United States

    3 h-index

    4 publications

    90 citations

  5. Boston University

    Boston, United States

    3 h-index

    12 publications

    1.2K citations

  6. University of California, San Francisco

    San Francisco, United States

    3 h-index

    10 publications

    238 citations

  7. Boston Collaborative Drug Surveillance Program

    Lexington, United States

    3 h-index

    12 publications

    1.2K citations

  8. Jones Institute

    Carlsbad, United States

    2 h-index

    2 publications

    38 citations

1–8 of 49

Venues

  1. Contraception

    9 publications · 494 citations

    9

    h-index

  2. Fertility and Sterility

    3 publications · 269 citations

    3

    h-index

  3. The Journal of Clinical Pharmacology

    2 publications · 100 citations

    2

    h-index

  4. Obstetrics and Gynecology

    2 publications · 145 citations

    2

    h-index

  5. Journal of Adolescent Health

    2 publications · 58 citations

    2

    h-index

1–5